Insmed Incorporated
INSM
$132.17
$3.853.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.72% | -11.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.72% | -11.12% | |||
| Cost of Revenue | 31.94% | -18.63% | |||
| Gross Profit | 10.90% | -8.62% | |||
| SG&A Expenses | 4.89% | 3.53% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.97% | -7.72% | |||
| Operating Income | -10.46% | 6.27% | |||
| Income Before Tax | -25.33% | -9.13% | |||
| Income Tax Expenses | 36.29% | -27.96% | |||
| Earnings from Continuing Operations | -25.37% | -8.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.37% | -8.93% | |||
| EBIT | -10.46% | 6.27% | |||
| EBITDA | -10.31% | 6.49% | |||
| EPS Basic | -19.78% | -7.82% | |||
| Normalized Basic EPS | -5.23% | 5.67% | |||
| EPS Diluted | -19.72% | -7.92% | |||
| Normalized Diluted EPS | -5.23% | 5.67% | |||
| Average Basic Shares Outstanding | 4.67% | 1.03% | |||
| Average Diluted Shares Outstanding | 4.67% | 1.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||